TOP1 and breast carcinoma: We report that TOP1 and CDH3 were expressed to a higher extent in BRCA1-related breast carcinomas relative to sporadic breast carcinomas, highlighting their potential clinical usefulness for breast cancer detection in women with a BRCA1 mutation.